{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:51Z","timestamp":1762001691611,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30771976"],"award-info":[{"award-number":["30771976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Important National Science & Technology Specific Projects","award":["2009ZX09301-014"],"award-info":[{"award-number":["2009ZX09301-014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejphar.2011.01.046","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T09:23:05Z","timestamp":1296897785000},"page":"119-124","source":"Crossref","is-referenced-by-count":12,"title":["Blocking TNF-\u03b1 by combination of TNF-\u03b1- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-induced colitis in rats"],"prefix":"10.1016","volume":"656","author":[{"given":"Bingjiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.01.046_bb0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0952-7915(99)00032-1","article-title":"Animal models of mucosal inflammation and their relation to human inflammatory bowel disease","volume":"11","author":"Blumberg","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","article-title":"Tumour necrosis factor alpha in stool as a marker of intestinal inflammation","volume":"339","author":"Braegger","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0025","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1073\/pnas.0508997103","article-title":"Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease","volume":"103","author":"Gonzalez-Rey","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.37.2.260","article-title":"Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease","volume":"37","author":"Hadziselimovic","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0035","first-page":"143","article-title":"Cytokines in inflammatory bowel disease","volume":"46","author":"Kmiec","year":"1998","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2567.2004.01984.x","article-title":"Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle","volume":"113","author":"Kolios","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0045","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","article-title":"Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models","volume":"87","author":"Krawisz","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0050","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1210\/en.2007-0978","article-title":"Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance","volume":"149","author":"Liang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"MacEwan","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0065","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.1994.tb06047.x","article-title":"IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease","volume":"96","author":"Mitsuyama","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/gut.32.8.913","article-title":"Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease","volume":"32","author":"Murch","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0075","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0022-3565(24)29641-5","article-title":"An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis","volume":"297","author":"Nakase","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation","volume":"160","author":"Peschon","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0090","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","article-title":"A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease","volume":"159","author":"Plevy","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0095","first-page":"389","article-title":"The cytokines in inflammatory bowel disease","volume":"63","author":"Polinska","year":"2009","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0100","first-page":"560","article-title":"Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis","volume":"118","author":"Popivanova","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0110","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0115","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinthera.2008.02.014","article-title":"A review of infliximab use in ulcerative colitis","volume":"30","author":"Wilhelm","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0140","first-page":"670","article-title":"Screening and identification of TNF-\u03b1 binding peptide and TNFR block peptide","volume":"34","author":"Yin","year":"2005","journal-title":"Acta Med. Univ. Sci. Technol. Huazhong"},{"key":"10.1016\/j.ejphar.2011.01.046_bb0145","first-page":"4","article-title":"Biological characteristics and effect of TNF\u03b1 binding peptide and TNFR blocking peptide in vitro","volume":"23","author":"Yin","year":"2007","journal-title":"Chin. J. Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2011.01.046_bb0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9440(10)64057-6","article-title":"Monocyte\/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease","volume":"158","author":"Zareie","year":"2001","journal-title":"Am. J. Pathol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991100104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991100104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T11:30:18Z","timestamp":1740915018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991100104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S001429991100104X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.01.046","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}